US House committee moves quickly to approve bill limiting business with Chinese biotech firms

Bipartisan legislation that would restrict US business with world-leading Chinese biotech companies and their subsidiaries was approved by a House of Representatives committee on Wednesday.

The House Committee on Oversight and Accountability passed the bill 40-1. To become law, the bill must pass the full House and Senate, then be signed by the president.